More about

Alzheimer's Disease

News
April 26, 2023
1 min read
Save

Topline results: Donanemab superior to aducanumab in early symptomatic Alzheimer’s disease

Topline results: Donanemab superior to aducanumab in early symptomatic Alzheimer’s disease

BOSTON — More patients with early symptomatic Alzheimer’s disease reached amyloid clearance and plaque reductions at 6 months with donanemab vs. aducanumab, according to a presentation at the American Academy of Neurology annual meeting.

News
April 18, 2023
1 min read
Save

FDA advisory committees rule in favor of Rexulti for agitation associated with Alzheimer’s

FDA advisory committees rule in favor of Rexulti for agitation associated with Alzheimer’s

Two FDA advisory committees voted in favor of a supplemental new drug application for Rexulti, ruling there was sufficient data to show treatment for agitation associated with Alzheimer’s dementia outweighed the risks.

News
April 18, 2023
2 min read
Save

Vascular dementia, Alzheimer’s disease influence outcomes for people with AF

Vascular dementia, Alzheimer’s disease influence outcomes for people with AF

Adults with atrial fibrillation and vascular dementia have a higher risk for stroke, rehospitalization and mortality compared with those with AF and Alzheimer’s disease, who have a higher risk for intercranial hemorrhage, data show.

News
April 17, 2023
1 min read
Save

Walgreens, Prothena partner to boost enrollment for Alzheimer’s disease clinical trial

Walgreens, Prothena partner to boost enrollment for Alzheimer’s disease clinical trial

Walgreens and Prothena have announced a partnership to expand patient identification and recruitment for Prothena’s ongoing study of PRX012, an investigational anti-amyloid beta antibody for the treatment of Alzheimer’s disease.

News
April 17, 2023
2 min read
Save

Omega-3 fatty acids might reduce cognitive decline risk

Omega-3 fatty acids might reduce cognitive decline risk

Omega-3 fatty acid may reduce the risk for cognitive decline and could be particularly helpful for populations at high genetic risk for Alzheimer’s disease, according to researchers.

News
April 13, 2023
1 min read
Save

Top in women’s health: Alzheimer’s disease vulnerability; ozone exposure during pregnancy

Top in women’s health: Alzheimer’s disease vulnerability; ozone exposure during pregnancy

Developing menopause at an earlier age and late initiation of hormone therapy were associated with increased vulnerability to Alzheimer’s disease, according to researchers.

News
April 10, 2023
2 min read
Save

Modified Mediterranean ketogenic diet may improve brain health

Modified Mediterranean ketogenic diet may improve brain health

A modified Mediterranean ketogenic diet was associated with changes in a biological pathway linked to Alzheimer’s disease among older adults with mild cognitive impairment, according to study results published in Alzheimer’s and Dementia.

News
April 10, 2023
1 min read
Save

Family of Estée Lauder donates $200M to Alzheimer’s research

Family of Estée Lauder donates $200M to Alzheimer’s research

The descendants of Estée Lauder donated $200 million to the Alzheimer’s Drug Discovery Foundation to help prevent, diagnose, treat and cure the disease, according to a press release.

News
April 07, 2023
1 min read
Save

Biogen’s investigational therapy reduced tau protein levels in patients with Alzheimer’s

Biogen’s investigational therapy reduced tau protein levels in patients with Alzheimer’s

Biogen Inc. has reported promising data from a phase 1b trial of BIIB080, an investigational antisense oligonucleotide therapy that reduced soluble tau protein in cerebrospinal fluid in patients with early Alzheimer’s disease.

News
April 03, 2023
2 min read
Save

Earlier age at menopause, later HT initiation linked to Alzheimer’s disease vulnerability

Earlier age at menopause, later HT initiation linked to Alzheimer’s disease vulnerability

Being younger at menopause onset and initiating hormone therapy after more than 5 years were both linked to increased tau vulnerability among women, according to a cross-sectional study published in JAMA Neurology.

View more